Delivery Order SPE2DB20D1047-SPE2DB25FF56V
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,041.80 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of VEVYE 0.1% eye drop solution in 2ML units. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to compete in...
- The Defense Logistics Agency awarded a $1,571.97 delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop (2ML) on September 26, 2025, with completion scheduled for September 29, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that...
- The Defense Logistics Agency awarded a $8,218.23 delivery order to AmerisourceBergen Drug Corp on May 13, 2025, for the supply of VEVYE 0.1% eye drops in 2ml quantities. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of May 14, 2025. This delivery order operates under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,438.39 to AmerisourceBergen Drug Corp for VEVYE 0.1% Eye Drop (2ML) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,047.98 for VEVYE 0.1% eye drop solution (2ml) on September 25, 2025, with completion scheduled for September 26, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a $1,105.62 firm fixed price delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drops (2ml) on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2ml) on June 2, 2025, with a ceiling value of $2,897. This is a firm fixed price, non-set-aside delivery order under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% Eye Drop (2ML) with a ceiling value of $2,509.24. This firm fixed price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by September 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.22 to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop (2ML) on September 22, 2025, with completion targeted for September 23, 2025. This is a firm fixed price, non-set-aside contract to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,765.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2ML) on July 21, 2025, with completion expected by July 22, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The product will be...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB25FF56VDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,727.57 to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drops (2ML) on April 25, 2025, with an ultimate completion date of April 28, 2025. This competitively awarded, firm fixed-price delivery order was placed to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a routine pharmaceutical procurement under the company's existing contract vehicle with the Defense Logistics Agency. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen serves military and veteran healthcare systems through this comprehensive global pharmaceutical support vehicle, which enables the delivery of a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency requirements and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 4/25/25 |